[Corrigendum] A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties

Han,Xiaofeng; Du,Fangfang; Jiang,Li; Zhu,Yifei; Chen,Zhen; Liu,Yanjun; Hong,Tingting; Wang,Teng; Mao,Yong; Wu,Xiaohong; Bruce,Iain C.; Jin,Jian; Ma,Xin; Hua,Dong

doi:10.3892/ol.2022.13526

November-2022 Volume 24 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

November-2022 Volume 24 Issue 5

Full Size Image

Correction Open Access

[Corrigendum] A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties

Authors:
- Xiaofeng Han
- Fangfang Du
- Li Jiang
- Yifei Zhu
- Zhen Chen
- Yanjun Liu
- Tingting Hong
- Teng Wang
- Yong Mao
- Xiaohong Wu
- Iain C. Bruce
- Jian Jin
- Xin Ma
- Dong Hua
View Affiliations / Copyright

Affiliations: School of Medicine, Jiangnan University, Wuxi, Jiangsu 214122, P.R. China, School of Pharmaceutical Sciences, Jiangnan University, Wuxi, Jiangsu 214122, P.R. China, Affiliated Hospital, Jiangnan University, Wuxi, Jiangsu 214122, P.R. China

Copyright: © Han et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 406
|
Published online on: September 26, 2022

https://doi.org/10.3892/ol.2022.13526
Expand metrics +

Article

Oncol Lett 6: [Related article:] 1295–1298, 2013; DOI: 10.3892/ol.2013.1568

Subsequently to the publication of this paper, an interested reader drew to the authors’ attention that, in Fig. 2A and 3A on p. 1296, there were a pair of apparently overlapping data panels (specifically, the data representing the tumor spheres for the A2780/PTX cells in Fig. 2A, and the tumor spheres for the control A2780/PTX cells in Fig. 3A). The authors have re-examined their data, and realized that the image shown correctly for Fig. 2A was inadvertently and erroneously included in Fig. 3A.

Figure 3.

Inhibition of PI3K activity blocks colony formation in A2780/PTX cells. (A) Representative images and (B) summary data showing the effect of the PI3K inhibitor, LY294002 (10 μM). Images of the cells were captured after 14 days (upper panels in A). Tumor spheres formed from 2,000 A2780/PTX cells, with and without LY294002 treatment (lower panels in A). Control indicates DMSO (0.1%). *P<0.05, compared with A2780/PTX cells without LY294002. DMSO, dimethyl sulfoxide.

The authors have reassembled Fig. 3, and the corrected version of this figure, now showing the correct data for the tumor spheres for the control A2780/PTX cells in Fig. 3A, is shown opposite. Note that this error did not have a major impact on either the results or the conclusions reported in this paper. The authors regret that this error went uncorrected before the paper was published, and are grateful to the Editor of Oncology Letters for allowing them to publish this Corrigendum. All the named authors agree to the publication of this Corrigendum, and apologize to the readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties

This article is mentioned in:

Article

Figure 3.

Related Articles